Bluestar Adisseo Company

600299

CNE000001253

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-21 EDT			5-day change	1st Jan Change
10.01 ^CNY	-0.60%		-0.10%	+25.12%

04-25	Bluestar Adisseo Company Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-25	Bluestar Adisseo Company announced that it expects to receive CNY 3 billion in funding	CI

Blue Star New Chemical Materials Co., Ltd. Provides Earnings Guidance for the Full Year 2015

January 26, 2016

Blue Star New Chemical Materials Co., Ltd. provided earnings guidance for the full year 2015. For the period, the company predicts its net profit belonging to shareholders to be over RMB 1.39 billion, a year-on-year increase of about 500%.

Latest news about Bluestar Adisseo Company

Bluestar Adisseo Company Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Bluestar Adisseo Company announced that it expects to receive CNY 3 billion in funding	04-24	CI
Elkem Names New Chair of the Board	04-22	MT
Bluestar Adisseo's 2023 Profit Plummets 96%	03-29	MT
Bluestar Adisseo Company Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Bluestar Adisseo Company Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Bluestar Adisseo to Invest 4.9 Billion Yuan Into Methionine Production Base	23-08-07	MT
Bluestar Adisseo Company Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-04	CI
Bluestar Adisseo Co., Ltd. Announces Executive Changes	23-06-30	CI
Bluestar Adisseo Co., Ltd Announces Board Changes	23-06-30	CI
Bluestar Adisseo Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Bluestar Adisseo Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Bluestar Adisseo Logs Over 15% Drop in 2022 Profit	23-02-16	MT
Bluestar Adisseo Company Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
UBS Upgrades Bluestar Adisseo to Buy From Neutral, Adjusts Price Target to 13 Yuan From 14.2 Yuan	22-08-01	MT
Bluestar Adisseo Company Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-28	CI
Bluestar Adisseo Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Bluestar Adisseo Company Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Bluestar Adisseo Company(SHSE:600299) dropped from Shanghai Stock Exchange Health Care Sector Index	21-12-10	CI
Bluestar Adisseo Company Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Calysta, Inc. announced that it has received $39 million in funding from BP Ventures Limited, Bluestar Adisseo Company, A-Spark Good Ventures, Westech Investment Advisors, Inc.	21-09-08	CI
Bluestar Adisseo Company Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-30	CI
Bluestar Adisseo Company Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Bluestar Adisseo Company Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Calysseo, A Joint Venture Between Adisseo and Calysta, Buildis First Facility in Chongqing, China	21-01-08	CI

Chart Bluestar Adisseo Company

Duration

Period

More charts

Company Profile

Bluestar Adisseo Co is a China-based company principally engaged in the research, design, production and distribution of additives for animal nutrition. The Companyâs products include functional products, special products and others. Its functional products include methionine, vitamins, ammonia sulfates, as well as sodium sulfates, among others. Its special products include enzyme preparations, organic selenium additives and others. The Company also provides carbon disulfide, sulfuric acid and preparation services. The Company operates its business in domestic and overseas markets.

Sector

Pharmaceuticals

Calendar

2024-07-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Bluestar Adisseo Company

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.01 CNY

Average target price

9.81 CNY

Spread / Average Target

-2.00%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
BLUESTAR ADISSEO COMPANY	+25.12%	3.71B
ZOETIS INC.	-12.83%	78.51B
ELANCO ANIMAL HEALTH INCORPORATED	+13.62%	8.37B
JINYU BIO-TECHNOLOGY CO., LTD.	-1.21%	1.64B
VIMIAN GROUP AB	+14.19%	1.64B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-18.97%	1.36B
VETOQUINOL SA	+2.34%	1.34B
WUHAN KEQIAN BIOLOGY CO.,LTD	-6.82%	1.22B
PULIKE BIOLOGICAL ENGINEERING, INC.	+4.02%	1.12B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	+2.32%	1.07B

Veterinary Drugs

Bluestar Adisseo Company

Equities

600299

CNE000001253

Pharmaceuticals

Blue Star New Chemical Materials Co., Ltd. Provides Earnings Guidance for the Full Year 2015

EPS Revisions